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Knowledge about protein kinase substrate prefer-
ences is biased toward residues immediately adja-
cent to the site of phosphorylation. By a combined
structural, biochemical, and cellular approach, we
have discovered an unexpected substrate recogni-
tion element with the consensus sequence PEF/Y in
the tumor suppressor death-associated protein
kinase 1. This motif can be effectively blocked by a
specific pseudosubstrate-type interaction with an
autoregulatory domain of this kinase. In this arrange-
ment, the central PEF/Y glutamate interacts with a
conserved arginine distant to the phosphorylation
site in sequence and structure. We also demonstrate
that the element is crucial for kinase activity regula-
tion and substrate recognition. The PEF/Y motif
distinguishes close death-associated protein kinase
relatives from canonical calcium/calmodulin-depen-
dent protein kinases. Insight into this signature and
mode of action offers new opportunities to identify
specific small molecule inhibitors in PEF/Y-contain-
ing protein kinases.
INTRODUCTION
The human kinome comprises more than 500 members, and
their abundance requires elaborate molecular mechanisms to
regulate their catalytic activity and to generate substrate speci-
ficity (Pellicena and Kuriyan, 2006; Ubersax and Ferrell, 2007).
About half of the serine/threonine (Ser/Thr) kinases utilize an
arginine or lysine located amino-terminally of the phosphorylated
residue as primary specificity determinant (Ben-Shimon and Niv,
2011; Zhu et al., 2005). Our knowledge of specificity-determining
factors in protein substrates is mostly focused on the two to
three residue positions next to their phosphorylation site (P0).
For most kinases, positional information beyond these initial res-
idues becomes ambiguous, yet several databases offer predic-264 Chemistry & Biology 21, 264–273, February 20, 2014 ª2014 Elsetions beyond these limits (Ellis and Kobe, 2011; Hornbeck
et al., 2012; Obenauer et al., 2003). However, synthetic peptide
scanning libraries tend to be insensitive to flexible residues
more remote from the central phosphorylation site (Alexander
et al., 2011; Yaffe et al., 2001). Novel structures of kinase/
substrate complexes could reveal interactions between the
phosphorylation site and residues that may be distal in the sub-
strate primary sequence but are in close proximity within the
folded structure (Bialik and Kimchi, 2012).
A substantial fraction of all protein kinases have an autoregu-
latory domain (ARD) that is C terminal to the catalytic kinase
domain (CD). The ARD can conditionally block the kinase active
site by pseudosubstrate-type interactions until its removal by
additional regulatory mechanisms such as calcium/calmodulin
(Ca2+/CaM) binding or site-specific phosphorylation (Kemp
et al., 1994). A molecular analysis of these pseudosubstrate in-
teractions would therefore provide new insights into the atomic
details of kinase substrate specificity. To test such an approach,
we have chosen death-associated protein kinase 1 (DAPK1) as a
model of an ARD-containing protein kinase to unravel hitherto-
unknown determinants of substrate specificity through a com-
bined structural, biochemical, and functional approach. DAPK1
is an important tumor suppressor, is used as a diagnostic and
prognostic tool during tumor development, and is a target for
drug development (Raval et al., 2007; Schumacher et al.,
2002). The protein contributes to development of the nervous
system, yet the increased kinetic activity after neuronal injury
or in neurodegenerative disease such as Alzheimer disease
can be detrimental on neuronal protection (Fujita and Yamashita,
2013). The kinase domain of DAPK1 belongs to a branch of the
kinome containing myosin light-chain-related kinases (MLCKs)
and triple functional domain protein-related kinases, collectively
referred to as DMT kinases (Temmerman et al., 2013).
Although previous positional scanning substrate library data
have revealed moderate preferences for residues at positions
next to the site of phosphorylation, an unambiguous substrate
preference profile is still missing (Bialik et al., 2008; Lin et al.,
2010; Velentza et al., 2001). Here, by direct structural compari-
son of different activity conformations of DAPK1, we discovered
a specific interaction that is only found when the ARD of this
kinase acts as pseudosubstrate. One of the binding partnersvier Ltd All rights reserved
Figure 1. Conformation-Dependent Interaction of DAPK1
Glu182(CD, PEF/Y)-Arg302(ARD) as a Protein Kinase Activity Sub-
strate Accessibility Determinant
(A) Surface representation of DAPK1 (apo conformation). Color codes: CD,
light green; ARD, yellow. The approximate trace of the extended ARD pseu-
dopeptide segment is indicated by a dotted line. The carboxylate groups of
Glu100 (GEL motif), Glu143 (PEN motif), and Glu182 (PEF/Y motif) are high-
lighted in red. Glu182 is blocked by Arg302 (guanidinium group in blue) from
the ARD and thus inaccessible for protein-substrate interactions.
(B–E) Close-ups of the boxed active site area show (B) apo-DAPK1 (WT) with
Glu182 substrate inaccessible, (C) DAPK1-Ca2+/CAM (WT) substrate acces-
sible, (D) apo-DAPK1 (R302A) substrate accessible, and (E) apo-DAPK1
(E182A) nonfunctional; the R302 side chain is invisible and therefore marked
between brackets. PEF/Y motif residues are labeled and colored in violet.
Dashed lines indicate hydrogen bonds or salt bridges.
Complete structures used for this analysis are shown in Figure S1.
Table 1. X-Ray Data Collection and Refinement Statistics
Protein name DAPK1 WT DAPK1 E182A DAPK1 R302A
PDB entry 2W4K 2XUU 4B4L
X-ray data collection
Space group P212121 P212121 P212121
Wavelength (A˚) 0.976 0.873 0.873
Cell dimensions
a, b, c (A˚)
49.3, 77.0,
108.9
49.7, 84.4,
86.3
49.4, 83.8,
84.6
Resolution (A˚)a 62.9-1.90
(2.00-1.90)
30.4-1.80
(1.90-1.80)
59.51.75
(1.84-1.75)
Completeness (%)a 97.8 (87.9) 100 (99.9) 100 (99.9)
Rsym
a 0.072 (0.535) 0.110 (0.560) 0.123 (0.991)
Mean (I/sI)a,b 11.7 (2.7) 9.3 (2.5) 12.7 (2.1)
Redundancya 3.7 (3.3) 4.0 (4.0) 6.7 (6.9)
Structure determination and refinement
Resolution (A˚) 62.9-1.90 30.4-1.80 59.51.75
No. reflections 30,930 34,469 34,315
Rcryst/Rfree 0.195/0.228 0.179/0.226 0.193/0.220
No. atoms protein/
ions/ligands/solvent
2,463/1/27/
271
2,411/16/27/
408
2,428/35/48/
266
B factors (A˚2) protein/
ligands/solvent
25.7/27.1/
38.3
18.3/23.4/
31.8
19.1/42.4/
28.9
Rmsd bond lengths (A˚) 0.012 0.026 0.020
Rmsd bond angles () 1.333 2.009 1.991
aValues in parentheses refer to highest-resolution shell.
bI/sI indicates the average of the intensity divided by its average SD. Rfree
is the same as Rvalue for the 5% of the data randomly omitted from
refinement.
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Substrate Recognition by the PEF/Y Motif in DAPK(Glu182) presents the central residue of the PEF/Y sequence
motif that is highly conserved in a well-defined subset of the
Ca2+/CaM-dependent family of the human kinome. Functional
in vitro and in vivo assays show that the removal of the side chain
of Glu182 in the PEF/Y motif is sufficient to inhibit kinase activity.
Likewise, we show that this motif can recognize distal (P-6) basic
residues on the ARD pseudosubstrate (Arg302) as well as on
peptide substrates.
RESULTS
Pseudosubstrate Interactions of the DAPK1
Autoregulatory Domain Are Conformation Dependent
As a starting point of our analysis, we used a recently determined
DAPK1 structure in the presence of CaM, which revealed the
complete ARD (residues 278–320) to be folded into a long a helix
pointing away from the CD (de Diego et al., 2010). In this struc-
ture, CaM binds tightly to the ARD autophosphorylation site
Ser308, thus sterically blocking this residue to become phos-Chemistry & Biology 21, 264phorylated and indicating this conformation to be incompatible
with that of a pseudosubstrate. To decipher a possible structural
role for the DAPK1 ARD as a pseudosubstrate, we determined a
complementary crystal structure of the same DAPK1 construct
(residues 1–334, abbreviated as DAPK1 throughout this paper)
in the presence of Mg2+/ADP and in the absence of CaM (Fig-
ure 1A; Table 1; Figure S1 available online). In contrast to the
structure of the DAPK1-CaM complex (de Diego et al., 2010),
part of the ARD beyond the Ser308 phosphorylation site (resi-
dues 303–334) remained invisible, indicating a transient binding
of Ser308 to the CD during autophosphorylation (Figure S2). In
this structure, previously established protein substrate recogni-
tion motifs GEL (Glu100) and PEN (Glu143) (Zhu et al., 2005)
are surface exposed and accessible. Figure S2 shows an over-
view of these motifs found in DAPK1.
Here, we focused on a comparison of ARD-CD interactions in
the portion of the ARD visible in both DAPK1 structures, in the
absence and presence of CaM (residues 278–302). The confor-
mation of the N-terminal ARD part (residues 280–296), preceding
the CaM-binding segment, is virtually identical in both struc-
tures; however, CaM binding induces significant alterations in
the visible ARD-CD interactions in the subsequent segment (res-
idues 297–302), most notably with Arg302 (Figures 1B and 1C).
Whereas in the apo-DAPK1 structure Arg302 interacts via a
direct salt bridge with the CD residue Glu182, next to the activa-
tion segment, in the DAPK1-CaM complex the same residue is
reoriented and involved in CaM interactions (de Diego et al.,–273, February 20, 2014 ª2014 Elsevier Ltd All rights reserved 265
Figure 2. Opposite Functional Effects of
DAPK1 Glu182 and Arg302 in Substrate
Recognition and Autoinhibiton Release
(A) apo-DAPK1, extended with a model of ARD
residues 303–311 (gray). The CD is shown by sur-
face presentation and the ARD by ribbon presen-
tation. Residuesmutated for functional studies and
relevant for autoinhibition or CaM binding are
labeled. Color codes are as in Figure 1.
(B and C) Histogram of steady-state activity
kinetics of DAPK1(CD) (B) or DAPK1 (C)
variants using an MLC-2-derived peptide
KKRPQRRYSNVF or variants in which either
positions P-6 or P-2 (underlined), in reference to
the phosphorylation site (in italics), or both have
been altered (for further details, see Table S1).
CaM absent, orange bars; CaM present, cyan
bars. Values of kcat/KM (specificity constant) are
indicated in ±SEM. NM signifies nonmeasurable;
the corresponding activity cannot be correctly
analyzed by Michaelis-Menten kinetics.
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interaction is essential for the ARD conformation observed in
the apo-DAPK1 structure, we also solved the structures of two
DAPK1 mutants, E182A and R302A, in which one of two side
chains required for salt-bridge formation was removed (Figures
1D and 1E; Figure S1). The two structures confirm that the
N-terminal ARD helix is formed and oriented as in the wild-type
(WT) DAPK1 structure, indicating that the Glu182-Arg302 inter-
action is not essential for maintaining any specific conformation
of the active site. Indeed, irrespective of whether Glu182 is
blocked by an interaction with Arg302 or surface exposed, its
consistent orientation in all structures is supported by a flanking
interaction with Ser215.
To ultimately understand the relation of the ARD pseudosub-
strate to different substrate binding motifs and to guide
designing further mutants in the pseudosubstrate segment of
the ARD, we modeled residues 303–311 that are subsequent
to the final visible residue in the apo-DAPK1 structure (Figure 2A;
Figure S1). This model correctly positions Ser308 (P0) at the
DAPK1 active site, in agreement with previous substrate peptide
complexes of phosphorylase kinase and CaMKII (Chao et al.,
2010; Lowe et al., 1997).266 Chemistry & Biology 21, 264–273, February 20, 2014 ª2014 Elsevier Ltd All rights reservBased on the structural data of auto-
inhibited DAPK1, we reasoned that
Arg302 could represent an important
pseudosubstrate P-6 specificity site for
Ser308 phosphorylation. Vice versa, our
data suggest that Glu182 could be a key
residue for recognizing the 6 position
of the DAPK1 ARD or, when released
from a pseudosubstrate conformation by
CaM binding, for recognizing structurally
equivalent positions in DAPK1 protein
substrates that are remote (i.e., five or
more residues) from the site of phosphor-
ylation. These hypotheses predict that
Glu182 removal should reduce or even
abolish DAPK1 kinetic activity whereasremoval of Arg302 could lead to an enhanced trans-phosphory-
lation activity by unblocking the Glu182 substrate recognition
site.
The Residue Pair Glu182-Arg302 in DAPK1 Functions as
a Substrate Recognition Module
To assess these potential functional roles, we measured the
kinase activity of several DAPK1 variants through two comple-
mentary approaches: (1) an enzymatic in vitro assay, using a
peptide derived from myosin regulatory light chain 12B
(MLC-2) as a potent substrate (de Diego et al., 2010; Velentza
et al., 2001); and (2) an in vivo cellular characterization of
DAPK1 variants.
The DAPK1 E182A mutant showed only residual in vitro enzy-
matic activity regardless of the presence of CaM (Figure 2C;
Table S1), indicating that this side chain is crucial for catalytic
DAPK1 activity. Indeed, even the activity of the unregulated
DAPK1(CD) E182A version, which lacks the ARD, was severely
impaired (Figure 2B; Table S1). The charge-reversal mutant
DAPK1(CD) E182R further reduced activity to a specificity con-
stant (kcat/KM) of about 1% of WT DAPK1. Because the position
of Glu182 suggests that it has no direct involvement in eithered
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strate, the most plausible structure-based explanation is that
its negatively charged side chain is essential for DAPK1 protein
substrate recognition. This finding is supported by isothermal
titration calorimetry (ITC) data showing that nucleotide binding,
with a Kd of 1–2 mM, is not affected by mutating E182. Conse-
quently, binding defects are confined to the DAPK1 peptide sub-
strate (Figure S3).
We also tested the DAPK1 activity effect by exchanging the
P-6 arginine in the MLC-2 peptide substrate (Figures 2B and
2C; Table S1) with a glutamine and glutamate, leading to effec-
tive charge reversal. The KM and specificity constant of the
P-6Q peptide variant were about half that of WT, with a further
4-fold reduction observed for the P-6E peptide. The unregulated
DAPK1(CD) even displayed a drop in KM toward the mM range
and a 10-fold reduced specificity constant. This observation is
remarkable considering the proximity to the N terminus of
the peptide used, which probably has a more floppy conforma-
tion. A charge inversion setup, using the P-6E peptide and
DAPK1(CD) E182R, was not able to restore the kinase activity.
Possibly, the DAPK1 E182R mutant engages in other interac-
tions within the kinase domain, rendering the residue inacces-
sible for substrate binding. When both P-6 and P-2 sites were
mutated to glutamine, we did not find any phosphorylation of
the respective MLC-2 peptide variant, demonstrating that the
two sites combined are essential for MLC-2 substrate recogni-
tion by DAPK1. These data are analogous to previous results
on MLC-2 phosphorylation by MLCK (Kemp et al., 1983). Inter-
estingly, these studies also indicated that extending the distance
between the physiological Ser19 phosphorylation site and the
basic residues normally around P-6 shifted the phosphorylation
presence to the neighboring Thr18 (Kemp and Pearson, 1985).
Compared to the loss of catalytic activity in the E182A mutant,
the opposite effect is seen when the interaction partner of
Glu182 in the DAPK1 apo conformation, Arg302 from the ARD,
is mutated. In the presence of CaM, DAPK1 activity is not
affected. However, the R302A mutation considerably releases
the activity inhibition in the absence of CaM, resulting in a kcat
equivalent to the level of CaM-bound WT DAPK1 (Figure 2C;
Table S1). Our structural data suggest that in the absence of
the Glu182-Arg302 salt bridge in apo-DAPK1, which is impaired
in the DAPK1 R302Amutant, Glu182 becomes accessible as the
substrate recognition site. For comparison, we also tested the
effects of the ARD P-2 site Lys306, previously characterized as
possible substrate recognition site in synthetic peptides (Ve-
lentza et al., 2001), and the two sites (Arg302 and Lys306) com-
bined. The respective DAPK1 variants (K306A and R302A +
K306A) show a similar effect on DAPK1 activity in the absence
of CaM; however, the increase in kcat of K306A alone is inferior
compared to that found for R302A. This could be because of
increasing flexibility of the ARD near the Ser308 phosphorylation
site, thus leading to less effective masking by the ARD of addi-
tional previously characterized kinase substrate recognition sites
(Zhu et al., 2005). The KM values of the ARD mutants do not
significantly differ from the WT enzyme, as the mutations do
not affect the kinase domain itself. The increased catalytic con-
stants kcat appear to depend on the facilitated release of the
ARD. The opposite is seen for the E182A mutation on the
kinase domain, which strongly influences the KM (Table S1).Chemistry & Biology 21, 264Whereas the CaM-bound form of DAPK1 represents an active
form of the protein, the opposite is achieved by S308 autophos-
phorylation, which inhibits CaM binding (Shohat et al., 2001).
Indeed, a phospho-mimicking DAPK1mutant S308D attenuated
the activating effect of R302A (Table S1). The level of S308 auto-
phosphorylation was not diminished in the DAPK1 ARD mutants
investigated, indicating that increased flexibility at the N-terminal
part of the DAPK1 ARD does not hinder positioning S308 into the
DAPK1 active site (Figure S4A). Indeed, the increased level of
autophosphorylation found in the DAPK1 R302A mutant may
indicate an enhancement of correct positioning of S308 into
the active site due to increased ARD flexibility, in the absence
of the E182-R302 salt bridge observed in the WT DAPK1 struc-
ture (Figure 1). In agreement with our structural data, the
DAPK1 mutants investigated do not have a significant effect on
CaM binding (Figure S4B). To assess the extent of S308 auto-
phosphorylation influence on kinetic experiments with added
CaM, DAPK1 was coexpressed with CaM (Table S1), effectively
shielding S308 for autophosphorylation. In agreement with the
determined autophosphorylation levels, the specificity constant
of DAPK1 WT is slightly increased and this effect is more pro-
nounced for DAPK1 R302A.
For our cellular assay, the setup of the in vitro kinetic experi-
ments was mimicked. First, we transfected human embryonic
kidney 293 (HEK293) cells with WT and mutant DAPK1(CD)
alone. Next, we applied WT and mutant DAPK1 without or with
thapsigargin (TG) treatment to activate DAPK1 by CaM binding.
Overexpressing the deregulated CD of DAPK1, without the ARD,
confirmed a strong blebbing effect (Figures 3A and 3B).Whenwe
removed theGlu182 side chain in the CD fragment, blebbingwas
reduced 2-fold. As for the biochemical experiments, the DAPK1
charge-reversal mutation E182R led to a further 2-fold reduction
in blebbing. This indicates that loss of this substrate recognition
site has a significant effect on cellular MLC-2 phosphorylation.
By contrast, regulated DAPK1 with the ARD attached did not
show significant blebbing, in agreement with previous studies
(Bialik et al., 2004; de Diego et al., 2010).
Next, we treated the cells with TG, which increases the intra-
cellular Ca2+ concentration and, concordantly, active Ca2+/
CaM. This approach confirmed that WT ARD-containing
DAPK1 could be activated by about 10-fold, whereas in E182A
this effect was considerably reduced (Figures 3A and 3B). The
influence of Arg302 and Lys306 on DAPK1 autoinhibition was
similarly characterized in the cellular assay but without the TG
treatment. Confirming the kinetic data in the absence of Ca2+/
CaM, the R302A mutation was sufficient to activate DAPK1 by
about 2-fold (Figure 3C). By contrast, K306A alone did not alter
the blebbing phenotype, nor was there a significant additive
effect when this mutation was combined with R302A.
DISCUSSION
Preferred sequence patterns near the site of phosphorylation,
generally up to two to three residues, have been systematically
analyzed for various kinases bywell-established profile scanning
approaches (Ubersax and Ferrell, 2007; Yaffe et al., 2001).
Based on these data, distinct substrate recognition sites have
been classified into motifs and comprise a glutamate or aspar-
tate embedded into highly conserved residues. Three such–273, February 20, 2014 ª2014 Elsevier Ltd All rights reserved 267
Figure 3. DAPK1 Glu182 Is Required for
MLC-2-Dependent Membrane Blebbing in
Cells
(A) Representative images of HEK293 cells ex-
pressing ECFP fusions of the indicated proteins.
Overexpression of DAPK1 CD causes dynamic
membrane blebbing (upper left panel), which is
reduced by the introduction of E182A (lower left
panel). Cells overexpressing WT or E182A DAPK1
display a normal morphology, unless treated with
thapsigargin (TG), with themost pronounced blebs
on WT cells (upper right panel).
(B and C) Relative amount of DAPK1 variant-
expressing cells showing membrane blebbing
24 hr (B) or 48 hr (C) posttransfection. Orange
bars, untreated cells; dark blue bars, cells with
TG added; CFP was used as control. For (B)
and (C), WT DAPK1 blebbing was normalized to 1;
the average of at least two independent ex-
periments ±SEM, each with n > 100, is depicted.
The actual percentage of blebbing cells is indi-
cated within the bar for each condition or variant.
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kinase active site, have been described in detail (Figure S2).
The final basic residue positional preference strongly depends
on the juxtaposition of each of these motifs, yet reasonable pre-
dictions can be made (Ben-Shimon and Niv, 2011). The general
motif GEL (residues 99–101 in DAPK1 and 127–129 in PKA C-a)
confers specificity toward position P-3 (Fujii et al., 2004; Yaffe
et al., 2001). This motif is found in most AGC kinases (including
the representative members cAMP-dependent protein kinase 1
[PKA], cGMP-dependent protein kinase, and protein kinase C)
as well as in CAMK family members. Two other motifs, PEN
and YEM, have been found to provide a strong preference
toward the P-2 site and, in some cases, toward the P-5 site
(Yang et al., 2002), of which only the PEN can be found in CAMKs
(142–144 in DAPK1 and 170–173 in PKA C-a). In addition, non-
conserved acidic patches have been found that confer prefer-
ence to basic residues on other sites, for example a DDD/E
signature (D226–228 in AMPKa-1) for P-6 in the AMPK/BRSK
branch of CAMKs (Scott et al., 2002).
In contrast, little is known about substrate conformational
requirements, which may translate in specific sequence prefer-
ences more remote from the site of phosphorylation. In this
study, we have identified and characterized a substrate recog-
nition motif that we refer to as PEF/Y (residues 181–183 in
DAPK1, 203–205 in PKA C-a) by direct comparison of DAPK1
structures in an autoinhibited conformation, in which the ARD
functions as pseudosubstrate, and in the presence of Ca2+/
CaM, which leads to DAPK1 activation. The central residue of268 Chemistry & Biology 21, 264–273, February 20, 2014 ª2014 Elsevier Ltd All rights reservthe PEF/Y, Glu182, recognizes the P-6
site (Arg302) of the DAPK1 ARD phos-
phorylation site (Ser308), and our struc-
tural data show that this site is in
an a-helical conformation, establishing
specific conformational restrictions in
placing and orienting all residues that
are located on the helical sequence
segment.In contrast to GEL and PEN, the PEF/Y motif is situated at the
lower lobe of DAPK1, within a hairpin turn that defines the
C terminus of the activation segment, and remote from the nucle-
otide-binding pocket (Figure 1A; Figure S2). Although the first
two residues of the PEF/Ymotif are invariant in all DAPK1-related
protein kinase sequences, the third residue of themotif is either a
phenylalanine or tyrosine (Figure 4). Our structural data indicate
that role of the proline is restricting and thus defining a highly
specific conformation and orientation of the PEF/Y-containing
loop. Themotif resides in the so-called P+1 loop due to its signif-
icance in accommodating the neighboring residue of the sub-
strate phosphorylation site in many kinases (Goldsmith et al.,
2007). PKA C-a residues L199, P203 (of the PEF/Y motif), and
L206 form a hydrophobic pocket for P+1 (Figure S2). Immedi-
ately following L206 is the generally conserved APE motif (Fig-
ure 4), which firmly anchors this entire loop to the F helix at the
core of the lower kinase lobe (Kornev and Taylor, 2010). Although
phosphorylation is a prerequisite of the activation loop and
consequent rearrangement in the P+1 loop/APE motif for PKA
C-a as for most kinases (Steichen et al., 2010), this is not the
case for DAPK. Instead, the activation loop is fixed by an alterna-
tive hydrophobic anchor unique to DMT kinases (Temmerman
et al., 2013), rendering the PEF/Y and P+1 loop immobile.
Remarkably, there is a sharp distinction between DAPK1-
related protein kinases (Temmerman et al., 2013) and canonical
CaM-dependent protein kinases, such as CaM kinases I–IV,
which lack the PEF/Ymotif (Figure 4; Table 2). Several structures
of the latter and peptide substrate complexes of CaMKII (Chaoed
Figure 4. Multiple Sequence Alignment of
the Residues Next to the PEF/Y Motif of
Representative Kinases of theCAMKFamily
Protein names, CD sequence range, position of
the central PEF/Y residue, and the level of
sequence similarity to DAPK1 (in %) are listed to
the left. Conserved PEF/Y motif residues are
colored in pink, and other conserved residues are
in light gray (cluster of similar amino acids) or dark
gray (invariant). DAPK1-related kinases that
establish a separate branch in a phylogenetic tree
of CAMK family kinases (Temmerman et al., 2013)
have the PEF/Y motif in common, whereas this
motif is missing in all canonical CaM kinases and
almost all other related kinases. A representative
selection of AGC kinases is given as reference.
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Substrate Recognition by the PEF/Y Motif in DAPKet al., 2010) confirm there is no specific recognition of the equiv-
alent site in DAPK1. The structures of the related CDs of DAPK2,
DAPK3, DRAK2, titin, and MLCK corroborate that this side chain
is spatially conserved within DAPK-related kinases. Moreover,
DAPK2 possesses an ARD highly similar to DAPK1 (Temmerman
et al., 2013) and is likely to follow the same regulation pattern as
described here for DAPK1. By contrast, DAPK3 contains a C-ter-
minal leucine zipper structure instead of an ARD (Kawai et al.,
1998), which consequently differs in activation mode and
undergoes autophosphorylation on nonconsensus sites (Pike
et al., 2008). The most remarkable autophosphorylation for
DAPK3 is on Thr180, immediately adjacent to the PEF/Y motif,
which promotes activation. Indeed, a T180A mutation abolishes
kinase activity (Graves et al., 2005). DAPKs are constitutively
active and do not require phosphorylation to switch the active
site on (Temmerman et al., 2013). Therefore, a DAPK3 T180 alter-
ation could lead to a direct relocation of the PEF/Y motif and a
subsequent effect on substrate affinity and kinase activity. In
the case of titin, which comprises an ARD-containing kinase
likely not regulated by CaM (Mayans et al., 2013; Temmerman
et al., 2013), the central PEF/Y glutamate instead interacts with
a tyrosine from the ARD N terminus (Mayans et al., 1998). This
interaction renders the active site inaccessible for protein sub-
strates and thus inactive. Interestingly, phosphorylation of
Tyr170 next to the PEF/Y motif in titin kinase has been shown
to activate this kinase, leading to a model in which loss of the
ARD interaction by Glu169 would render the PEF/Y motif acces-
sible as a substrate recognition site.
Next to the CAMK family, the PEF/Ymotif is also present in the
vast majority of AGC kinases (Figure 4; Table 2). However, anyChemistry & Biology 21, 264–273, February 20, 2014functional implications remain largely
uninvestigated to date. The only known
example has been a study on PKA that
used a structure of this kinase in complex
with a peptide substrate (Moore et al.,
2003). In this structure, the peptide argi-
nine at P-6 interacts with the central
PEF/Y glutamate as well, reminiscent to
our observations in DAPK1. As for the
DAPK1 ARD, the PKA peptide substrate
P-6 position is within an a-helical environ-
ment, which impacts the site’s posi-tioning within the kinase active site. Similar to DAPK1, mutation
of the PEF/Y glutamate in PKA reduces catalytic activity. The ex-
pected general significance of the PEF/Ymotif in other members
of the human kinome is underlined by observations of at least
three kinases, by screening specific cancer cell lines, for which
mutations in this motif give rise to a pathological phenotype
(Table 2).
A crucial question remains whether PEF/Y-mediated remote
substrate recognition is a common property of all PEF/Y motif-
comprising kinases (Table 2). Our data and previous structural
studies on DAPK1 substrates (Lin et al., 2010) indicate that there
is a conformational tolerance around the substrate residue at
P-6, with some substrates forming loop regions and others
helices (Figure 5). This may explain why there may be positional
tolerance in the recognition of trans-phosphorylation substrates,
rendering a sequence-based substrate recognition pattern less
obvious. Ultimately, structural constraints in potential substrates
could serve as an additional parameter beyond mere sequence
constraints, thus introducing a new concept in deciphering sub-
strate specificity in protein kinases. It would also be interesting to
further investigate how our findings on the importance of the
PEF/Y in regulating DAPK1 activity combines with other regula-
tory mechanisms such as additional sites for phosphorylation to
generate potentially even more activated or inhibited conforma-
tional states of this and related kinases.
SIGNIFICANCE
Protein kinases have substantial variation in the pro-
tein substrate recognition sites, leading to highly specificª2014 Elsevier Ltd All rights reserved 269
Table 2. Human Kinase Genes with a PEF/Y Motif
DAPK related PEF DAPK1, DAPK2, DAPK3, KALRN, MYLK,
MYLK2, MYLK3, MYLK4, OBSCN SPEG, TRIO
PEY DRAK1, DRAK2, TTN
AGC family PEF PKN1, PKN2, PKN3
PEY AKT1, AKT2, AKT3, DMPK*, DMPK2*, MAST1,
MAST2, MAST3, MAST4, MRCKa*, MRCKb*,
PRKACA, PRKACB, PRKACG, PRKCA*,
PRKCD*, PRKCD*, PRKCE*, PRKCG*,
PRKCH*, PRKCQ*, PRKG1, PRKG2, PRKX,
PRKY, SGK1, SGK2, SGK3, STK38*, STK38L*,
ROCK1*, ROCK2*
Other PEF Wnk1, Wnk2, Wnk3, Wnk4
PEY CAMKV, PSKH1, PSKH2, SCYL2
Classification into groups according to the kinase family and type of motif
(Manning et al., 2002). Genes for which cancer-related mutations have
been identified within the PEF/Y motif are in bold (SGK2 and E259K
Greenman et al., 2007; MRCKb and D241H; Wang et al., 2007; KALRN
and E2844G; Barretina et al., 2012). AGC family members containing
an equivalent PDY variant of PEY are marked with an asterisk.
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are recognized linearly by specific residues next to the site
of phosphorylation that bind to kinase-specific sequence
motifs within or near the active site. However, increasing
evidence is emerging that substrate sequence features
more remote from the site of phosphorylation and their
structural conformation may have crucial contributions to
specific kinase/substrate relations as well. To address this
point, we have used death-associated protein kinase as a
model, as its mode of activity regulation is well established.
Here, we have discovered a sequence motif (we refer to as
PEF/Y) that recognizes the –6 position (Arg302) in an a-heli-
cal conformation of the C-terminal pseudosubstrate region
of this kinase in its autoinhibited state. Our structural and
complementary functional data indicate that this PEF/Y
motif is crucial for the recognition of equivalent positions
in other trans-substrates of this kinase as well. Because
the PEF/Y motif is only found in specific groups of protein
kinases, including those closely related to death-associated
protein kinase, it has a capacity to serve asmarker of protein
kinase substrate specificity. Our data advance the under-
standing of the mechanistic basis of substrate recognition
by kinases. Structure-based substrate recognition could
provide a kinase-specific fingerprint, opening new leads
on kinase inhibitors that do not target the active site. In the
case of death-associated protein kinase, for which activity
is linked to both tumor suppression and neuronal degrada-
tion, specific inhibitors for one pathway are highly desirable.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification
Homo sapiens DAPK1 (CD, residues 1–285) and DAPK1 (residues 1–334) were
amplified by PCR from a full-length human DAPK1 cDNA and cloned into
pETM11 and pETM30 vectors, respectively. For cellular experiments, the
same constructs were cloned into a pECFP-C1 vector (Clontech). Site-
directed mutagenesis by PCR was used to generate DAPK mutant variants.
Cells were grown in Luria broth (LB) media supplemented with 30 mg/ml kana-270 Chemistry & Biology 21, 264–273, February 20, 2014 ª2014 Elsemycin to an optical density 600 of 0.6–0.8. Protein expression was induced
at 20C for 16 hr in the presence of 200 mM isopropyl b-D-1-thiogalactopyra-
noside. For purification of the DAPK1 variants, cells were harvested and
sonicated in 300mMNaCl, 5% glycerol, 20 mM imidazole (pH 8), 8 mM 2-mer-
captoethanol, and protease inhibitors buffered in 50 mM HEPES (pH 7.2).
Cleared supernatants were filtered and applied to Ni-NTA beads (QIAGEN)
and protein was eluted with 300mM imidazole. For kinase activity assays, cells
were harvested and sonicated in 150 mM NaCl, 5% (v/v) glycerol, 0.5 mM
tris(2-carboxyethyl)phosphine (TCEP), 10 mg/ml lysozyme, and protease inhib-
itors buffered in 50mMHEPES (pH 7.2); the protein was applied to Glutathione
Sepharose 4B (GEHealthcare) and eluted with 10mMglutathione. In all cases,
protein was dialyzed overnight to 120mMNaCl, 4mMCaCl2, and 8mM2-mer-
captoethanol (0.5 mM TCEP for kinetic assays), buffered in 30 mM HEPES
(pH 7.2), in the presence of TEV protease at a 1:50 molar ratio for tag cleavage.
The cleaved tag was removed and samples were further purified by size exclu-
sion chromatography. Selected fractions were collected and concentrated to
10–17mg/ml (for crystallization) or 1–1.6 mg/ml (for kinase activity assays). For
crystallization purposes, 1 mM phenylmethanesulfonylfluoride (PMSF) was
added to the final protein solution.
X-Ray Data Collection and Structure Determination
Crystals were obtained by the sitting drop vapor diffusion technique at the
EMBL Hamburg Crystallization Facility. A total of 0.2–0.3 ml of protein were
dissolved at 12–17 mg/ml in 30 mM HEPES (pH 7.2), 120 mM NaCl, 6 mM
CaCl2, 8 mM 2-mercaptoethanol, and 1 mM PMSF and mixed with an equal
volume of reservoir buffer. Crystallization drops were equilibrated at 19C
against 80 ml of reservoir buffer, including 5 mMMgCl2 and 5mM ADP, except
for DAPK1(R302A). DAPK1(WT) crystals were obtained from 170 mM
(NH4)2SO4, 25% [w/v] PEG 4000, and 15% (v/v) glycerol. DAPK1(E182A) crys-
tals were obtained from 200 mM Li2SO4, 25% (w/v) PEG 4000 buffered in
100 mM Bis-Tris (pH 5.5). DAPK1(R302A) crystals were obtained in 200 mM
(NH4)2SO4 and 25% (w/v) PEG 3350 buffered in 100 mM Bis-Tris (pH 5.5).
Each crystal form was verified by MALDI-TOF (Applied Biosystems, Voyager)
on protein completeness.
Crystals were shock frozen in mother liquor, and X-ray data were collected
at 100 K. X-ray data sets were collected at beamlines BM14 (EMBL Grenoble/
European Synchrotron Radiation Facility [ESRF]), ID29 (ESRF), and X11 (EMBL
Hamburg/DESY). For further details, see Table 1. Different single-wavelength
data sets were collected using an ADSCQuantum-4CCDdetector at beamline
BM14 (2W4K) or aMARMosaic 225-CCDdetector at ID23-2 (2XUU and 4B4L),
both at ESRF. Data were processed mainly within the CCP4 suite (Collabora-
tive Computational Project, Number 4, 1994; Potterton et al., 2004). X-ray data
were reduced using the programs MOSFLM (Leslie, 2006) and SCALA (Evans,
2006). Phases were determined by molecular replacement using the program
PHASER (McCoy et al., 2007) using the structure of the DAPK1 catalytic
domain (1JKL) as the search model. Model building and refinement was car-
ried with COOT (Potterton et al., 2004) and REFMAC5 (Murshudov et al.,
1997), respectively. Visible electron densities, used to identify the crystal
structures in the study, comprise residues 2–302 (WT and E182A) and residues
5–303 (R302A). Coordinates and structure factors have been submitted to the
PDB database with the accession codes 2W4K, 2XUU, and 4B4L. Complete
statistics are shown in Table 1. The respective Ramachandran statistics indi-
cating the fraction of residues in the favored/allowed/outlier regions of the
Ramachandran diagram as defined by MOLPROBITY (Chen et al., 2010) are
98.3/1.7/0.0 (2W4K), 98.7/1.0/0.3 (2XUU), and 98.3/1.7/0.0 (4B4L). Figures
were prepared using the Molecular Graphics System PyMOL (Schro¨dinger).
In Vitro Kinase Activity Assays
The kinetic activity of DAPK variants was analyzed using an in vitro kinase
assay in which ATP consumption is coupled to the oxidation of NADH through
pyruvate kinase and lactate dehydrogenase (Cook et al., 1982; Roskoski,
1983). Reactions were performed at 30C in 100 ml reaction mixtures contain-
ing 2 U pyruvate kinase, 2 U lactate dehydrogenase, 2 mM phosphoenolpyr-
uvate, 0.4 mM NADH, 0.5 mM CaCl2, 10 mM KCl, 20 mM MgCl2, and
0.2 mM DTT buffered in 60 mM HEPES (pH 7.2). The reaction mix, containing
the ATP substrate, was incubated for 1 min at 30C and initiated by the addi-
tion of the peptide substrate in a 2-fold dilution series. Saturating concentra-
tions of ATP (2 mM) and peptide (500 mM) were determined empirically asvier Ltd All rights reserved
Figure 5. Sequence Representation of
the Best-Described Human Substrates or
Pseudosubstrates of DAPK1
The relative position to the phosphorylated res-
idue (in green) as well as the respective position of
the phosphorylated residue is indicated. Basic
residues are colored in blue and acidic residues in
red. If available, PDB IDs of the respective sub-
strates are stated. In case a secondary structure is
formed within the indicated sequence, this is
highlighted. *Placopecten magellanicus structure,
66% sequence identity to the indicated human
sequence; **Sus scrofa structure, 100% sequence
identity to the indicated human sequence; n/a, no
structure available.
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Peptide substrate (KKRPQRRYSNVF) and variants (Velentza et al., 2001)
were at least 90% pure (GenScript). Measurements were performed for 1 hr
at 340 nm in a plate reader (TECAN, Infinite M1000), as described previously
(Kiianitsa et al., 2003). Titrations were performed in duplicate with three inde-
pendent repetitions using 500, 250, 125, 62.5, and 31.25 mM as peptide con-
centrations with saturating ATP concentrations. The reaction constants were
calculated under pseudo-single-substrate conditions, in which one of the sub-
strates was kept at saturating concentration. The reaction follows simple
Michaelis-Menten kinetics, applied for calculation of the constants using a
nonlinear least-squares best fit of the data with GraphPad Prism (version
5.00, GraphPad Software). For each experiment, at least three independent
measurements were used (0–500 mM peptide substrate range). Kinetic exper-
iments, in the presence of Ca2+/CaM, were performed by mixing purified
DAPK1 and Ca2+/CaM (at 10-fold molar excess) to take into account possible
secondary effects such as potential differences in CaM binding and Ser308
autophosphorylation by different DAPK1 variants. We compared this setup
with a previously established coexpression and purification protocol (de Diego
et al., 2010), which maximizes enrichment of DAKP1/CaM complexes. When
DAPK1 and Ca2+/CaM were mixed, WT DAPK1 reached an activity level of
about half that of the coexpressed and purified DAPK1/CaM complex (Table
S1). This ratio was confirmed for the DAPK1 (R302A) mutant; hence, Arg302
removal does not induce major secondary effects.
To further assess the proteins properties for the kinase activity assay, we
analyzed S308 autophosphorylation levels. A total of 10 mg of the respective
purified recombinant DAPK1 was treated for 30 min with 5 mM Mg2+ and
1 mM ATP to correct for purification variations. Samples were separated by
SDS-PAGE and analyzed by western blot using an anti-DAPK1 phosphoS308
antibody (D4941, Sigma-Aldrich). Bands were visualized using a horseradish-
peroxidase-tagged secondary anti-mouse antibody. The analysis was per-
formed in triplicate and a representative blot is shown (Figure S4A). In addition,
the CaM binding capacity of DAPK1 variants was analyzed by pull-down.
CaM Sepharose (17-0529-01 GE Healthcare Life Sciences) was incubated
with 100 mg of the respective purified DAPK1 in the presence of 5mM Ca2+
for 1 hr. The supernatant was collected and analyzed by SDS-PAGE together
with the beads, which were washed extensively before analysis. The
analysis was performed in triplicate and a representative gel image is shown
(Figure S4B).
Cellular Blebbing Assays
Cellular activity of DAPK1 through MLC-2 phosphorylation was determined
with a plasma membrane blebbing assay (Bialik et al., 2004; Bovellan et al.,
2010). Human embryonic kidney 293T (HEK293T) cells were transfected with
Fugene (Promega) or lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions. For microscopy experiments, cells were plated out
24 hr before transfection on glass bottom dishes (MatTek) and live cells
were imaged 24 or 48 hr posttransfection with a 253 or a 633 objective on
an UltraVIEW VoX (Perkin Elmer) confocal microscope or on an AxioObserver
Z1 (Carl Zeiss MicroImaging) inverted fluorescence microscope. Where indi-
cated, cells were treated with 2.5 mM TG for 15 min before imaging. Images
were processedwith ImageJ; cells were scoredmanually into either a blebbing
or normal phenotype. For each replicate, the percentage of blebbing cells forChemistry & Biology 21, 264DAPK1WTwas normalized to 1 to exclude environmental effects, resulting in a
relative blebbing ratio as compared toWT. The percentage of blebbing cells on
the total imaged cells is also depicted in Figure 3. Equal kinase expression was
confirmed by fluorescence intensity in microscopy and control flow cytometric
analysis (MoFlo cell sorter, Beckman Coulter). FITC Annexin V (BD Biosci-
ences) and propidium iodide staining in flow cytometry were used to determine
the vitality of the cells as described (van Engeland et al., 1998). This control
analysis did not show significant differences in apoptosis or necrosis for the
DAPK1 variants used compared to control enhanced cyan fluorescent protein
(ECFP)-transfected cells.
Sequence Alignments
Protein phosphorylation targets of DAPK1 and the corresponding sequences
were retrieved from the Phospho.ELM database (Dinkel et al., 2011) and sup-
plemented with literature data (Lin et al., 2010). Sequences near known
phosphorylation sites were manually aligned and visualized with Jalview
(Waterhouse et al., 2009). The kinase domain sequences of human CAMK
and DAPK-related kinases were retrieved from UniProt (http://www.uniprot.
org/), aligned with ClustalW; Thompson et al., 1994) within Jalview, by select-
ing at least one representative member from each branch of the CAMK family
(Manning et al., 2002). For the grouping of PEF/Y motif-containing kinases
listed in Table 2, all 518 human kinase domains listed in the KinBase database
(http://kinase.com/kinbase) were aligned and examined for the presence of
the motif. Likewise, a CAMK phylogenetic tree was acquired from the same
database and node age calculation and visualization were done with FigTree
(v1.4.0; http://tree.bio.ed.ac.uk/software/figtree).
Model Generation of an Extended DAPK1 Version, Including a
Ser308 Autophosphorylation Site
The purpose of modeling an extended DAPK1 fragment was to confirm intra-
molecular phosphorylation of Ser308 as a plausible mechanism, thus allowing
structural details of the ARD—to the extent that they are visible in experimental
structures—to be considered as a pseudosubstrate. We used a previously
determined structure of phosphorylase kinase, which shares 28% sequence
identity with DAPK1, in complex with a seven-residue substrate peptide
(Protein Data Bank [PDB] code 2PHK), as a template. The peptide in this
structure (RQMSFRL) matches most residues 305–311 (WKQSVRL) that are
missing in our DAPK1 structure (PDB code 2W4K), taking the phosphorylation
site as a reference. Upon superposition of 2PHK and 2W4K, initially we
removed the first two residues of the peptide to allow annealing with the
C-terminal residue Arg302 in 2W4K and mutated those residue positions
that differ in 2PHK and 2W4K (Gln307 and Val309). Subsequently, a prelimi-
nary model was built by inserting four residues (KKWK, residues 303–306)
and refined with FlexPepDock (Raveh et al., 2010). The tenmost highly scoring
models were optimized via molecular dynamics simulation software (NAMD
version 2.7b4; Phillips et al., 2005) with Amber force field. After optimization,
the model with the lowest energy was selected as the final DAPK1 (2-311)
model. An alternative model (not displayed) was also generated with the
same approach starting from the structure of CaMKII (PDB ID 3KK8). Both
models produced the same overall conformation with minor differences in
side-chain orientation. The coordinates of the phosphorylase kinase-based
model are available in 3D Molecular Model S1.–273, February 20, 2014 ª2014 Elsevier Ltd All rights reserved 271
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Coordinates and structure factors have been submitted to the PDB database
with the accession codes 2W4K, 2XUU, and 4B4L.
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